aTyr Pharma Competitors and Similar CompaniesClear all
aTyr Pharma's competitors and similar companies include Catalyst Pharmaceuticals and Merus.
 Catalyst Pharmaceuticals Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases. |  Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. | ||
Founding Date | Founding Date 2005 | Founding Date 2002 | Founding Date 2003 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ | Locations Coral Gables, US HQ | Locations Utrecht, NL HQ Cambridge, US |
Employees | Employees 4235% decrease | Employees 7649% increase | Employees 260 |
Valuation ($) | Valuation ($) 131.1 m | Valuation ($) 2.6 b | Valuation ($) 3.6 b |
Financial | |||
Revenue (est.) | Revenue (est.) $190k (FY, 2025) | Revenue (est.) $589m (FY, 2025) | Revenue (est.) $36.1m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods $87.3m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $501.7m (FY, 2025) | Gross profit $36.1m (FY, 2024) |
Net income | Net income ($74.1m) (FY, 2025) | Net income $214.3m (FY, 2025) | Net income ($215.3m) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Catalyst Pharmaceuticals
HQ
Coral Gables, US
Employees
76↑ 49% increase
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.
View companyMerus
HQ
Utrecht, NL
Employees
260
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
View company